Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

about

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

Item

http://www.wikidata.org/entity/Q40456709

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

@en

type

Item

label

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

@en

prefLabel

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

@en

P1476

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.

@en

P2093

Bassim Al Bahrani

http://www.w3.org/2001/XMLSchema#string

P2860

Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis

Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors

Minocycline in acne vulgaris: benefits and risks.

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells

Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.

Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis.

Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.

Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.

Minocycline: far beyond an antibiotic.

NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer.

P304

231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00231

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ajit Venniyoor

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27833902

http://www.w3.org/2001/XMLSchema#string

P932

5081343

http://www.w3.org/2001/XMLSchema#string